Portfolio company
KANVAS
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company develops spatial biology imaging technology and microbiome-based therapeutics for healthcare providers treating cancer and infectious diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Kanvas Biosciences
This company develops microbiome mapping platforms and live biotherapeutic products for pharmaceutical companies and research institutions focused on treating cancer and inflammatory diseases.
AKYA
This company provides spatial phenotyping solutions to researchers and clinicians for visualizing and quantifying protein and RNA expression in tissue sections.
2NA FISH
The company develops spatial transcriptomics technology using nanotechnology and AI to provide precision diagnostics for healthcare providers and researchers.
mbiomics
This company develops live bacterial therapeutics and a microbiome profiling platform to treat patients with cancer and inflammatory bowel diseases.
Micrographia Bio
This company develops AI-driven microscopy and spatial proteomics platforms to help drug developers and researchers visualise molecular interactions and identify therapeutic targets.
lunaphore
This company develops spatial biology platforms and automated tissue analysis systems for laboratories, hospitals and researchers to advance cancer diagnostics and drug development.
Cartography Biosciences
This deep-tech company develops precision cancer therapeutics and drug targets for healthcare providers using computational biology and machine learning platforms.
Waypoint Bio
This company develops cell therapies for solid tumours using a spatial biology and machine learning platform to assist patients with difficult-to-treat cancers.
